Kimia Biosciences Ltd to Hold Board Meeting for Q1 2026 Un-Audited Financial Results
Kimia Biosciences Limited has scheduled a meeting of its Board of Directors to consider and approve the Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th, 2026. The board meeting is set to be held on Monday, August 10, 2026.In line with regulations concerning insider trading, Kimia Biosciences Limited has closed the trading window for its Designated Persons and their immediate relatives. This restriction became effective starting July 1, 2026. The restricted trading period will remain in effect until the completion of 48 hours following the declaration of the unaudited Financial Results for the first quarter ended June 30th, 2026, to the Stock Exchange.
Stock Price Movement
Kimia Biosciences Ltd shares settled at ₹31.68 on Monday, edging higher after closing up 0.22%. The stock navigated an intraday range, trading between a low of ₹31.60 and a high of ₹32.25.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.